Compare QURE & MEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QURE | MEG |
|---|---|---|
| Founded | 1998 | 2012 |
| Country | Netherlands | United States |
| Employees | 248 | 3500 |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 930.8M |
| IPO Year | 2013 | 2020 |
| Metric | QURE | MEG |
|---|---|---|
| Price | $17.61 | $21.40 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 4 |
| Target Price | ★ $44.92 | $35.25 |
| AVG Volume (30 Days) | ★ 1.6M | 221.9K |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 29.67 | ★ 93.69 |
| EPS | N/A | ★ N/A |
| Revenue | $13,107,000.00 | ★ $830,538,000.00 |
| Revenue This Year | $126.12 | $5.41 |
| Revenue Next Year | $200.43 | $7.19 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 19.26 |
| 52 Week Low | $8.73 | $13.75 |
| 52 Week High | $71.50 | $32.00 |
| Indicator | QURE | MEG |
|---|---|---|
| Relative Strength Index (RSI) | 53.07 | 41.12 |
| Support Level | $13.47 | $21.01 |
| Resistance Level | $18.37 | $23.67 |
| Average True Range (ATR) | 1.33 | 0.91 |
| MACD | 0.27 | -0.03 |
| Stochastic Oscillator | 87.86 | 28.75 |
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.
Montrose Environmental Group Inc is an environmental services company. The firm's operating segments are Assessment, Permitting and Response, Measurement and Analysis, and Remediation and Reuse. Through its Assessment, Permitting, and Response segment, the company provides scientific advisory and consulting services to support environmental assessments, environmental emergency response, and environmental audits and permits. Measurement and Analysis include test and analysis of air, water, and soil to determine concentrations of contaminants whereas, the Remediation and Reuse segment provide clients with engineering, design, implementation, operations and maintenance services, to treat contaminated water, and soil remediation. The company derives maximum revenue from United States.